Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Olanow

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 1, 1994
Magnetic resonance imaging of neurodegenerative diseasesR A Hauser, C W Olanow
Neurology|October 1, 1991
Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's diseaseJ M Cedarbaum, C W Olanow
Neurosurgery|January 1, 1981
Phenytoin: pharmacokinetics and clinical therapeuticsC W Olanow, A L Finn
Biochimica Et Biophysica Acta|March 17, 1999
Apoptosis in neurodegenerative diseases: the role of mitochondriaW G Tatton, C W Olanow
Annals of Neurology|April 13, 2000
Preventing levodopa-induced dyskinesiasC W Olanow, J A Obeso
Neurology|January 9, 2001
Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitorsC W Olanow, J A Obeso
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1981
Brain stem glioma in childhood: acute hemiplegic onsetS J Rothman, C W Olanow
Annals of Neurology|September 28, 1998
The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to realityC D Marsden, C W Olanow
Arquivos De Neuro-Psiquiatria|September 1, 1982
[Neurologic manifestations of hyperparathyroidism. Study of 120 cases]G N Rizzo, C W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's diseaseR A Hauser, C W Olanow
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 1, 1994
Magnetic resonance imaging of neurodegenerative diseasesR A Hauser, C W Olanow
Neurology|October 1, 1991
Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's diseaseJ M Cedarbaum, C W Olanow
Neurosurgery|January 1, 1981
Phenytoin: pharmacokinetics and clinical therapeuticsC W Olanow, A L Finn
Biochimica Et Biophysica Acta|March 17, 1999
Apoptosis in neurodegenerative diseases: the role of mitochondriaW G Tatton, C W Olanow
Annals of Neurology|April 13, 2000
Preventing levodopa-induced dyskinesiasC W Olanow, J A Obeso
Neurology|January 9, 2001
Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitorsC W Olanow, J A Obeso
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1981
Brain stem glioma in childhood: acute hemiplegic onsetS J Rothman, C W Olanow
Annals of Neurology|September 28, 1998
The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to realityC D Marsden, C W Olanow
Arquivos De Neuro-Psiquiatria|September 1, 1982
[Neurologic manifestations of hyperparathyroidism. Study of 120 cases]G N Rizzo, C W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's diseaseR A Hauser, C W Olanow
Pageof 13